This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Gemoscan Announces Stronger Financial Results For Q2 2014

TORONTO, Nov. 29, 2013 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. (TSX-V:GES) (MUN:1GE) ("Gemoscan" or the "Company"), a leading owner and marketer of food sensitivity and dietary management solutions, today reported operational and financial results for the 6 months and second fiscal quarter ended September 30, 2013. In this press release, all dollar amounts are expressed in Canadian currency and results are reported in accordance with International Financial Reporting Standards (IFRS).

Continued better than expected results were generated by the Company's on going focus on distribution to the consumer through the emerging retail health care sector including traditional pharmacies and paramedical clinics. The Company's programs are available in nearly 600 pharmacies and paramedical clinics across Canada.

The current financial results reflect the Company's previously announced acquisition of Physiomed Kennedy Inc. (the "Clinic"), a multidisciplinary paramedical clinic, and consolidate the August and September 2013 financial results for the Clinic.

For the six months ended September 30, 2013, total revenues were $1,041,196, representing an increase of 95% from $533,370, over the comparative six-month period in fiscal 2012. Fiscal second quarter revenues were $667,302, representing an increase of 138% over $280,629, for the comparative three-month period in fiscal 2012.

For the six months ended September 30, 2013 the Company also reported a lower than expected net loss of $622,128, as compared to $1,109,214 for the comparative period in fiscal 2012. Lower than expected fiscal second quarter net loss of $386,681 was also reported, versus $571,663 for the comparative period in fiscal 2012.

The Company also reported a significant reduction to cash used for operating activities for the 6 months ended September 30, 2013, of $217,395 versus $576,056, for the comparative period in fiscal 2012.

All of the Company's financial statements and management's discussion and analysis are available on www.sedar.com.

About Gemoscan Canada, Inc.

Gemoscan is an industry leader in food intolerance management and maintains a first-to-market position with Canada-wide distribution through select retail partners. Founded in 2003, using its proprietary patented technology, Gemoscan develops, owns and markets comprehensive food sensitivity and dietary management solutions for consumers, including the HEMOCODE™ Food Intolerance System and the MenuWise™ Food Intolerance Plan, personalized naturopathically supervised nutritional programs that promote well-being. Gemoscan is the first and only provider to commercialize a food intolerance management solution directly to consumers in partnership with retailers, and today offers the most comprehensive services available. Gemoscan also owns and operates Physiomed Kennedy Inc., a multidisciplinary paramedical clinic, located in Toronto, Ontario.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs